ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: February 2015. Rejuvenation Res, 2015; 18:90–95.
2.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: April 2015. Rejuvenation Res, 2015; 18:188–193.
3.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: June 2015. Rejuvenation Res, 2015; 18:282–288.
4.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: August 2015. Rejuvenation Res, 2015; 18:376–381.
5.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: October 2015. Rejuvenation Res, 2015; 18:484–489.
6.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: December 2015. Rejuvenation Res, 2015; 18:585–590.
7.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: February 2016. Rejuvenation Res, 2016; 19:94–99.
8.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: April 2016. Rejuvenation Res, 2016; 19:176–181.
9.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: June 2016. Rejuvenation Res, 2016; 19:256–262.
10.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: October 2016. Rejuvenation Res, 2016; 19:430–436.
11.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: December 2016. Rejuvenation Res, 2016; 19:525–530.
12.
SwistonAJ, ChengC, UmSH, IrvineDJ, CohenRE, RubnerMF. Surface functionalization of living cells with multilayer patches. Nano Lett, 2008; 8:4446–4453.
13.
GalindoMI, PueyoJI, FouixS, BishopSA, CousoJP. Peptides encoded by short ORFs control development and define a new eukaryotic gene family. PLoS Biol, 2007; 5:e106.
14.
HashimotoY, ItoY, NiikuraT, ShaoZ, HataM, OyamaF, NishimotoI. Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein. Biochem Biophys Res Commun, 2001; 283:460–468.
15.
BoominathanA, VanhoozerS, BasistyN, PowersK, CramptonAL, WangX, FriedricksN, SchillingB, BrandMD, O'ConnorMS. Stable nuclear expression of ATP8 and ATP6 genes rescues a mtDNA Complex V null mutant. Nucleic Acids Res, 2016; 44:9342–9357.
16.
ShigaK, HaraM, NagasakiT, SatoT, TakahashiH, TakeyamaH. Cancer-associated fibroblasts: Their characteristics and their roles in tumor growth. Cancers (Basel), 2015; 7:2443–2458.
17.
KoczorowskaMM, TholenS, BucherF, LutzL, KizhakkedathuJN, De WeverO, WellnerUF, BiniossekML, StahlA, LassmannS, SchillingO. Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations. Mol Oncol, 2016; 10:40–58.
18.
MendelsohnAR, LarrickJW. Thymus maintenance and regeneration by specific molecular factors. Rejuvenation Res, 2016; 19:90–93.
19.
BakerDJ, WijshakeT, TchkoniaT, LeBrasseurNK, ChildsBG, van de SluisB, KirklandJL, van DeursenJM. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature, 2011; 479:232–236.
20.
ReboJ, MehdipourM, GathwalaR, CauseyK, LiuY, ConboyMJ, ConboyIM. A single heterochronic blood exchange reveals rapid inhibition of multiple tissues by old blood. Nat Commun, 2016; 7:13363.
21.
NurkovicJ, VolarevicV, LakoM, ArmstrongL, ArsenijevicN, StojkovicM. Aging of stem and progenitor cells: Mechanisms, impact on therapeutic potential, and rejuvenation. Rejuvenation Res, 2016; 19:3–12.
22.
MendelsohnAR, LarrickJW. Aging stem cells lose the capability to distribute damaged proteins asymmetrically. Rejuvenation Res, 2015; 18:581–584.
23.
MendelsohnAR, LarrickJW. Stem cell depletion by global disorganization of the H3K9me3 epigenetic marker in aging. Rejuvenation Res, 2015; 18:371–375.
24.
WangX, ZouX, ZhaoJ, Wu XE L, FengL, WangD, ZhangG, XingH, LiuH. Site-specific characteristics of bone marrow mesenchymal stromal cells modify the effect of aging on the skeleton. Rejuvenation Res, 2016; 19:351–361.
25.
CorteseFA, SantostasiG. Whole-body induced cell turnover: A proposed intervention for age-related damage and associated pathology. Rejuvenation Res, 2016; 19:322–336.
26.
RenaudJ, NabaviSF, DagliaM, NabaviSM, MartinoliMG. Epigallocatechin-3-gallate, a promising molecule for Parkinson's disease?. Rejuvenation Res, 2015; 18:257–269.
27.
WangY, KrishnaS, GolledgeJ. The calcium chloride-induced rodent model of abdominal aortic aneurysm. Atherosclerosis, 2013; 226:29–39.
28.
MendelsohnAR, LarrickJW. Preclinical reversal of atherosclerosis by FDA-approved compound that transforms cholesterol into an anti-inflammatory “Prodrug.” Rejuvenation Res. 2016; 19:252–255.
